Equillium Inc (EQ)
0.721
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 13:51
Equillium Revenue (Quarterly): 12.16M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 12.16M |
June 30, 2024 | 13.85M |
March 31, 2024 | 10.69M |
December 31, 2023 | 9.211M |
Date | Value |
---|---|
September 30, 2023 | 8.87M |
June 30, 2023 | 9.124M |
March 31, 2023 | 8.879M |
December 31, 2022 | 15.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.87M
Minimum
Sep 2023
15.76M
Maximum
Dec 2022
11.07M
Average
9.95M
Median
Revenue (Quarterly) Benchmarks
Matinas BioPharma Holdings Inc | -- |
Tenon Medical Inc | 0.887M |
Alphatec Holdings Inc | 150.72M |
Madrigal Pharmaceuticals Inc | 62.18M |
Spero Therapeutics Inc | 7.819M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.007M |
Total Expenses (Quarterly) | 12.84M |
EPS Diluted (Quarterly) | -0.0002 |
Enterprise Value | -0.3668M |
Profit Margin (Quarterly) | -0.06% |
Earnings Yield | -19.44% |
Normalized Earnings Yield | -19.44 |